Gene aberrations for precision medicine against lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene aberrations for precision medicine against lung adenocarcinoma

Published:2016-05-25 Issue:6 Volume:107 Page:713-720
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Saito Motonobu¹²,Shiraishi Kouya¹,Kunitoh Hideo³,Takenoshita Seiichi²,Yokota Jun¹⁴,Kohno Takashi¹

Affiliation:

1. Division of Genome Biology National Cancer Center Research Institute Tokyo Japan

2. Department of Organ Regulatory Surgery Fukushima Medical University School of Medicine Fukushima Japan

3. Department of Medical Oncology Japanese Red Cross Medical Center Tokyo Japan

4. Cancer Genome Biology Group Institute of Predictive and Personalized Medicine of Cancer Barcelona Spain

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12941

Reference69 articles.

1. Lung cancer in never smokers — a different disease

2. Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity

3. RETfusion gene: Translation to personalized lung cancer therapy

4. Non–Small Cell Lung Cancer and Precision Medicine

5. Oncogene addiction

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets;Molecular Cancer;2024-09-02

2. Usefulness of endoscopic ultrasound with bronchoscope-guided fine-needle aspiration for next-generation sequencing in patients with non-small cell lung cancer: A comparison with other bronchoscopic techniques;Respiratory Investigation;2024-09

3. An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma;Discover Oncology;2024-08-29

4. Prognostic Factors in Japanese EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort Study;Drugs - Real World Outcomes;2024-08-29

5. SGPP2 is activated by SP1 and promotes lung adenocarcinoma progression;Anti-Cancer Drugs;2024-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3